Roquefort Therapeutics plc (ROQ.L)
GBp 1.85
(-8.11%)
GBp 1.85
(-8.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.08 Million GBP | -21.62% |
| 2022 | 7.76 Million GBP | 70.35% |
| 2021 | 4.56 Million GBP | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.07 Million GBP | -0.24% |
| 2024 Q2 | 6.07 Million GBP | 0.0% |
| 2023 Q4 | 6.08 Million GBP | 0.0% |
| 2023 FY | 6.08 Million GBP | -21.62% |
| 2023 Q3 | 6.08 Million GBP | -14.5% |
| 2023 Q2 | 7.12 Million GBP | 0.0% |
| 2023 Q1 | 7.12 Million GBP | -8.33% |
| 2022 Q3 | 7.76 Million GBP | 63.24% |
| 2022 Q2 | 4.75 Million GBP | 0.0% |
| 2022 FY | 7.76 Million GBP | 70.35% |
| 2022 Q4 | 7.76 Million GBP | 0.0% |
| 2022 Q1 | 4.75 Million GBP | 4.36% |
| 2021 Q2 | 893.68 Thousand GBP | 0.0% |
| 2021 Q4 | 4.56 Million GBP | 0.0% |
| 2021 FY | 4.56 Million GBP | 0.0% |
| 2021 Q1 | 893.68 Thousand GBP | 667.57% |
| 2020 Q3 | 116.43 Thousand GBP | 0.0% |
| 2020 Q4 | 116.43 Thousand GBP | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|